Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance

被引:30
|
作者
Metcalfe, John Z. [1 ]
Streicher, Elizabeth [2 ,3 ]
Theron, Grant [2 ,3 ]
Colman, Rebecca E. [4 ]
Allender, Christopher [5 ]
Lemmer, Darrin [5 ]
Warren, Rob [2 ,3 ]
Engelthaler, David M. [5 ]
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, 1001 Potrero Ave,Rm 5K1, San Francisco, CA 94110 USA
[2] Stellenbosch Univ, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Tygerberg, South Africa
[3] Stellenbosch Univ, Fac Med & Hlth Sci, SAMRC Ctr TB Res, Div Mol Biol & Human Genet, Tygerberg, South Africa
[4] Univ Calif San Diego, Div Pulm Crit Care & Sleep Med, San Diego, CA 92103 USA
[5] Translat Genom Res Inst, Flagstaff, AZ USA
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
next-generation sequencing; Sanger sequencing; drug-resistant tuberculosis; diagnostics; DRUG-RESISTANCE; FLUOROQUINOLONE RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; HETERO-RESISTANCE; GENOMIC ANALYSIS; SOUTH-AFRICA; HETERORESISTANCE; SUSCEPTIBILITY; MUTATIONS; DIAGNOSIS;
D O I
10.1164/rccm.201703-0556OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Minority drug-resistant Mycobacterium tuberculosis subpopulations can be associated with phenotypic resistance but are poorly detected by Sanger sequencing or commercial molecular diagnostic assays. Objectives: To determine the role of targeted next-generation sequencing in resolving these minor variant subpopulations. Methods: We used single molecule overlapping reads (SMOR), a targeted next-generation sequencing approach that dramatically reduces sequencing error, to analyze primary cultured isolates phenotypically resistant to rifampin, fluoroquinolones, or aminoglycosides, but for which Sanger sequencing found no resistance-associated variants (RAVs) within respective resistance-determining regions (study group). Isolates also underwent single-colony selection on antibiotic-containing agar, blinded to sequencing results. As a positive control, isolates with multiple colocalizing chromatogram peaks were also analyzed (control group). Measurements and Main Results: Among 61 primary culture isolates (25 study group and 36 control group), SMOR described 66 (49%) and 45 (33%) of 135 total heteroresistant RAVs at frequencies less than 5% and less than 1% of the total mycobacterial population, respectively. In the study group, SMOR detected minor resistant variant subpopulations in 80% (n = 20/25) of isolates with no Sanger-identified RAVs (median subpopulation size, 1.0%; interquartile range, 0.2-3.9%). Single-colony selection on drug-containing media corroborated SMOR results for 90% (n = 18/20) of RAV-containing specimens, and the absence of RAVs in 60% (n = 3/5) of isolates. Overall, Sanger sequencing was concordant with SMOR for 77% (n = 53/69) of macroheteroresistant (5-95% total population), but only 5% of microheteroresistant (< 5%) subpopulations (n = 3/66) across both groups. Conclusions: Cryptic minor variant mycobacterial subpopulations exist below the resolving capability of current drug susceptibility testing methodologies, and may explain an important proportion of false-negative resistance determinations.
引用
收藏
页码:1191 / 1201
页数:11
相关论文
共 50 条
  • [31] Reversal of Mycobacterium tuberculosis phenotypic drug resistance by 2-aminoimidazole- based small molecules
    Ackart, David F.
    Lindsey, Erick A.
    Podell, Brendan K.
    Melander, Roberta J.
    Basaraba, Randall J.
    Melander, Christian
    PATHOGENS AND DISEASE, 2014, 70 (03): : 370 - 378
  • [32] Correlation between phenotypic and genotypic drug resistance to kanamycin and amikacin in clinical isolates of Mycobacterium tuberculosis
    Ahmadi, Azam
    Sadrnia, Maryam
    Arjomandzadegan, Mohammad
    Titov, Leonid
    IRANIAN JOURNAL OF MICROBIOLOGY, 2020, 12 (05) : 503 - 504
  • [33] Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides
    Radhakrishnan, Ramalingam
    Prabuseenivasan, S.
    Hannah, S.
    Vaishanavee, V.
    Senthildevi, V
    Kannadhasan, T.
    Suchithra, R.
    Rajendran, Priya
    Chinnaiyan, Ponnuraja
    Jayabal, Lavanya
    Frederick, Asha
    Shanmugam, Sivakumar
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2023, 12 (03) : 299 - 304
  • [34] Characterization of phenotypic and genotypic drug resistance patterns of Mycobacterium tuberculosis isolates from a city in Mexico
    Flores-Trevino, Samantha
    Morfin-Otero, Rayo
    Rodriguez-Noriega, Eduardo
    Gonzalez-Diaz, Esteban
    Raul Perez-Gomez, Hector
    Mendoza-Olazaran, Soraya
    Balderas-Renteria, Isaias
    Maria Gonzalez, Gloria
    Garza-Gonzalez, Elvira
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (03): : 181 - 185
  • [35] Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review
    Irina Kontsevaya
    Jim Werngren
    Yen Holicka
    Kadri Klaos
    Anh Tran
    Vladyslav Nikolayevskyy
    European Journal of Clinical Microbiology & Infectious Diseases, 2020, 39 : 415 - 426
  • [36] Mutations in the rrs A1401G Gene and Phenotypic Resistance to Amikacin and Capreomycin in Mycobacterium tuberculosis
    Sirgel, Frederick A.
    Tait, Marisa
    Warren, Robin M.
    Streicher, Elizabeth M.
    Boettger, Erik C.
    van Heiden, Paul D.
    Gey van Pittius, Nicolaas C.
    Coetzee, Gerrit
    Hoosain, Ebrahim Y.
    Chabula-Nxiweni, Mamisa
    Hayes, Cindy
    Victor, Thomas C.
    Trollip, Andre
    MICROBIAL DRUG RESISTANCE, 2012, 18 (02) : 193 - 197
  • [37] Discrepancy in the genotypic versus phenotypic testing for resistance to rifampicin in Mycobacterium tuberculosis. A case report
    Rapun Mas, Loreto
    Angulo Lopez, Itziar
    Cecilio Irazola, Alvaro
    Betran Escartin, Ana Isabel
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2019, 37 (03): : 212 - 213
  • [38] Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance-India, 2018-2020
    Tamilzhalagan, Sembulingam
    Justin, Evanslin Santus
    Selvaraj, Ashok
    Venkateswaran, Karthick
    Sivakumar, Arun Kumar
    Chittibabu, Suganthi
    Mclaughlin, Heather P.
    Moonan, Patrick K.
    Smith, Jonathan P.
    Suba, Sakthi
    Narayanan, Mukesh Kumar Sathya
    Ho, Christine S.
    Kumar, Nishant
    Tripathy, Srikanth P.
    Shanmugam, Siva K.
    Hall-Eidson, Patricia J.
    Ranganathan, Uma Devi
    FRONTIERS IN MICROBIOLOGY, 2025, 15
  • [39] Utility of Phenotypic and Genotypic Testing in the Study of Mycobacterium tuberculosis Resistance to First-Line Anti-Tuberculosis drugs
    Alba Alvarez, Luz Maria
    Garcia Garcia, Jose Maria
    Dolores Perez Hernandez, M.
    Martinez Gonzalez, Susana
    Palacios Gutierrez, Juan Jose
    ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (04): : 192 - 198
  • [40] Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review
    Kontsevaya, Irina
    Werngren, Jim
    Holicka, Yen
    Klaos, Kadri
    Tran, Anh
    Nikolayevskyy, Vladyslav
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2020, 39 (03) : 415 - 426